COVID-19 mRNA Vaccine and Myocarditis

Coronavirus disease 2019 (COVID-19) is believed to have originated in the Hua nan South China Seafood Market in Wuhan and can present with a spectrum of clinical manifestations. We report the case of 24-year-old male patient who developed chest pain after administration of the second dose of the Pfi...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Balraj, Kaur, Parminder, Cedeno, Leon, Brahimi, Taulant, Patel, Prem, Virk, Hartaj, Shamoon, Fayez, Bikkina, Manesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SMC Media Srl 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276934/
https://www.ncbi.nlm.nih.gov/pubmed/34268277
http://dx.doi.org/10.12890/2021_002681
Descripción
Sumario:Coronavirus disease 2019 (COVID-19) is believed to have originated in the Hua nan South China Seafood Market in Wuhan and can present with a spectrum of clinical manifestations. We report the case of 24-year-old male patient who developed chest pain after administration of the second dose of the Pfizer-BioNTech mRNA COVID-19 vaccine and who was diagnosed with myocarditis on work-up. LEARNING POINTS: Localized injection site reactions and systemic adverse effects can occur after administration of the various COVID-19 vaccines. Healthcare providers should maintain a high index of suspicion regarding myocarditis after mRNA COVID-19 vaccination in the appropriate clinical scenario.

Ejemplares similares